Q&A

Reshaping Drug Development With 3D Screen Printing

GettyImages-2166388455-scientists-computer-screen-smiling-equipment

3D screen printing represents a major breakthrough in drug development by eliminating many of the limitations seen with traditional manufacturing methods, enabling intricate geometries, complex release profiles, and multiple APIs combined in a single tablet.

In this Q&A, Adare Pharma Solutions SVP of Global Sales and Marketing Steven Facer, joined by Laxxon Medical COO Klaus Kühne, describe the capabilities of Laxxon’s 3D screen printing platform for pharmaceutical production. The discussion describes the production process itself, prototyping, IP protection, release profile possibilities, and more.

access the Q&A!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Delivery Leader? Subscribe today.

Subscribe to Drug Delivery Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Drug Delivery Leader

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Adare Pharma Solutions